Evidence map›Paper›PMID 35901210›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

On the number of trials needed to distinguish similar alternatives.

Flavio Chierichetti, Ravi Kumar, Andrew Tomkins

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Flavio ChierichettiDipartimento di Informatica, Sapienza University of Rome, Rome, Italy 00185.ORCID 0000-0001-8261-9058
Ravi KumarGoogle, Mountain View, CA 94043.ORCID 0000-0002-2203-2586
Andrew TomkinsGoogle, Mountain View, CA 94043.ORCID 0000-0002-1611-9255

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A/B testing is widely used to tune search and recommendation algorithms, to compare product variants as efficiently and effectively as possible, and even to study animal behavior. With ongoing investment, due to diminishing returns, the items produced by the new alternative B show smaller and smaller improvement in quality from the items produced by the current system A. By formalizing this observation, we develop closed-form analytical expressions for the sample efficiency of a number of widely used families of slate-based comparison tests. In empirical trials, these theoretical sample complexity results are shown to be predictive of real-world testing efficiency outcomes. These findings offer opportunities for both more cost-effective testing and a better analytical understanding of the problem.

Indexed as

discrete choicesample complexitystatistical testing

Identifiers

PMID35901210
PMCPMC9351503

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.